Veeva Systems is wading into the fight between Medidata and Oracle for the EDC market.

SoftBank is teaming up with Saudi Arabia’s sovereign wealth fund to invest up to $100 billion in tech companies over the next five years.

PierianDx has bought Tute Genomics to gain the genomics platform it built up over its four years of operation and through the takeover of Knome.

Zymergen has raised $130 million to advance its machine learning-enabled microbe design business.

Y Combinator alum Benchling has raised $7 million to advance its cloud electronic lab notebook and CRISPR design software.

Elemental Machines is shipping its sensor-enabled smart lab system to cut the time it takes to pinpoint causes of variability and reproducibility problems.

Amadeus Capital and Jonathan Milner have teamed up to invest in Healx, a startup working with patient advocacy groups to repurpose drugs for rare diseases.

Recursion Pharmaceuticals has raised $12.9 million to scale up its computer-driven approach to drug development.